SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 12th, 2024 • Tenax Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 12th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 8, 2024, between Tenax Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
TENAX THERAPEUTICS, INC. and DIRECT TRANSFER LLC as Warrant Agent Warrant Agency Agreement Dated as of February 12, 2024 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • February 12th, 2024 • Tenax Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 12th, 2024 Company Industry JurisdictionWARRANT AGENCY AGREEMENT, dated as of February 12, 2024 (“Agreement”), between Tenax Therapeutics, Inc., a Delaware corporation (the “Company”), and Direct Transfer LLC, a Delaware limited liability trust company (the “Warrant Agent”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 12th, 2024 • Tenax Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 12th, 2024 Company Industry Jurisdiction